Peter Preston
Overview
Explore the profile of Peter Preston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neuman M, Feng R, Ellenberg S, Sieber F, Sessler D, Magaziner J, et al.
Ann Intern Med
. 2022 Jun;
175(7):952-960.
PMID: 35696684
Background: The REGAIN (Regional versus General Anesthesia for Promoting Independence after Hip Fracture) trial found similar ambulation and survival at 60 days with spinal versus general anesthesia for hip fracture...
2.
Stephens-Shields A, Farrar J, Ellenberg S, Storer T, Gill T, Basaria S, et al.
J Am Geriatr Soc
. 2020 Nov;
69(2):517-523.
PMID: 33210287
Background/objectives: Accurate estimates of clinically important difference (CID) are required for interpreting the clinical importance of treatments to improve physical function, but CID estimates vary in different disease populations. We...
3.
Shaikh K, Ellenberg S, Nakanishi R, Snyder P, Lee J, Wenger N, et al.
J Clin Endocrinol Metab
. 2019 Dec;
105(7).
PMID: 31784747
Objective: Recent results from the Cardiovascular Trial of the Testosterone Trials showed that testosterone treatment of older men with low testosterone was associated with greater progression of noncalcified plaque (NCP)....
4.
Cunningham G, Ellenberg S, Bhasin S, Matsumoto A, Parsons J, Preston P, et al.
J Clin Endocrinol Metab
. 2019 Sep;
104(12):6238-6246.
PMID: 31504596
Context: Prostate-specific antigen (PSA) changes during testosterone treatment of older hypogonadal men have not been rigorously evaluated. Design: Double-blinded, placebo-controlled trial. Setting: Twelve US academic medical centers. Participants: Seven hundred...
5.
Stephens-Shields A, Wang C, Preston P, Snyder P, Swerdloff R
J Sex Med
. 2019 May;
16(7):951-953.
PMID: 31101538
Background: A recent study of older men participating in the Testosterone Trials (TTrials) defined a clinically meaningful change in the Psychosexual Daily Questionnaire (PDQ) question 4 in hypogonadal men age...
6.
Bhasin S, Ellenberg S, Storer T, Basaria S, Pahor M, Stephens-Shields A, et al.
Lancet Diabetes Endocrinol
. 2018 Oct;
6(11):879-890.
PMID: 30366567
Background: The Physical Function Trial (PFT) was one of seven Testosterone Trials (TTrials), the aim of which was to assess the effect of testosterone on mobility, self-reported physical function, falls,...
7.
Wang C, Stephens-Shields A, Derogatis L, Cunningham G, Swerdloff R, Preston P, et al.
J Sex Med
. 2018 Jul;
15(7):997-1009.
PMID: 29960633
Background: Limited information is available on the performance characteristics of 2 questionnaires commonly used in clinical research, the Psychosexual Daily Questionnaire (PDQ) and the Derogatis Interview for Sexual Function (DISF)-II...
8.
Scattone Silva R, Purdam C, Fearon A, Spratford W, Kenneally-Dabrowski C, Preston P, et al.
Med Sci Sports Exerc
. 2017 Jul;
49(12):2517-2527.
PMID: 28704344
Purpose: This study aimed to verify the immediate effects of altering sagittal plane trunk position during jump landings on lower limb biomechanics, patellar tendon force, and pain of athletes with...
9.
Keith M, Wilson R, Preston P, Copley J
Clin Ther
. 2014 Jul;
36(9):1276-86.
PMID: 25069799
Purpose: Sevelamer hydrochloride (SH) and lanthanum carbonate (LC) are calcium-free phosphate binders used in the clinical management of hyperphosphatemia in patients with end-stage renal disease (ESRD). The objective of this...
10.
Urena-Torres P, Prie D, Keddad K, Preston P, Wilde P, Wan H, et al.
BMC Nephrol
. 2014 Jun;
15:71.
PMID: 24885942
Background: High levels of circulating fibroblast growth factor 23 (FGF23) are associated with chronic kidney disease (CKD) progression and high mortality. In the Phosphate Reduction Evaluation of FGF23 in Early...